Dashboards are data driven clinical decisions support used in analysis of data from multiple data sets. Dashboards are useful in promoting data driven decisions making and evidence based clinical approaches (Thorlund et al., 2020). Therefore, dashboard tools are critical in the healthcare sector as they assist in analysis and comprehension of data into a readable and easy format. This implies that dashboard metrics enable for analysis of shortfalls in an entity’s key performance indicators (KPI). Presentation of multiple data using color-coded graphical display that is easy to read can enhance understanding of organization’s performance. According to Dagliati et al., (2018) the adoption of visual approaches in reporting a healthcare’s performance allows for establishing the actual condition or performance.
The scope of this paper is to evaluate the current organization concerning the presented metrics and comparing with the benchmarks set forth by the government laws and policies at both the state, local and Federal levels. Besides, this report will advocate for ethical action to address benchmark underperformance and the potential for improving the overall quality of care and performance as reflected on the performance dashboard. From the analysis of the entity’s diabetic dashboard metrics, it’s evident that there is a need to address these shortfalls to enhance improvement in deliver of quality care.
The healthcare organization’s diabetes benchmark data is an indicator of how the entity is performing relating to diabetes management. This data is also critical in informing stakeholders on how well the organization is able to test and screen patients with diabetes. The benchmark data incorporate different screening and testing interventions such as eye examination, foot exams and HgbA1C. These are some of the most critical parameters that inform on the etiology of diabetes in patients. From a critical examination of the patient’s case, it’s evident that there are certain metrics that need to be improved it at all the healthcare facility will attain its strategic objectives. The results indicate a gradual decrease in eye exam from Q1 of 2019 to Q4 of the same year. The diabetic foot exams decreased substantially from the first quarter of 2018 to the fourth quarter of 2019. In the subsequent year, there was an increase in HgbA1C exams in Q1 and a decline in the other three quarters. This benchmark has portrayed a dismal performance throughout 2019 in comparison to the previous year therefore, warranting an in-depth assessment. The implications of this aspect are that the healthcare entity has not advanced significant resources towards this area. Therefore, a reduction in patient’s care could be witnessed in the facility due to these variations. Besides, underperformance of this metric indicates that the patients and the community could experience negative health consequences such as increased mortality and morbidity attributed to diabetes due to this aspect.
Struggling with online classes or exams? Get expert help to ace your coursework, assignments, and tests stress-free!